Depo-Provera associated with weight gain in Navajo women

被引:42
作者
Espey, E [1 ]
Steinhart, J
Ogburn, T
Qualls, C
机构
[1] Univ New Mexico, Hlth Sci Ctr, Dept Obstet & Gynecol, Albuquerque, NM 87131 USA
[2] Indian Hlth Serv, No Navajo Med Ctr, Shiprock, NM USA
[3] Univ New Mexico, Hlth Sci Ctr, Clin Res Ctr, Albuquerque, NM 87131 USA
关键词
Depo-Provera; Navajo; weight;
D O I
10.1016/S0010-7824(00)00144-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Depo-medroxyprogesterone acetate (DMPA) is an increasingly popular contraceptive choice among Navajo women. Weight gain is cited as a common side effect and major reason fur discontinuation of DMPA. No controlled trials have evaluated the association between weight gain and DMPA in Navajo women. We aimed to clarify whether DMPA is associated with weight gain in Navajo women and to quantify the magnitude of weight gain. A cohort of 172 Navajo women who had used DMPA continuously for one or 2 years comprised the study group. A cohort of 134 Navajo women who used a non-progestin method or no method over 1 or 2 years comprised the comparison group. Initial weight, one-year weight and 2-year weights were recorded for all patients. Study subjects gained a mean of 6 pounds over one year and 11 pounds over 2 years relative to the comparison group (p < 0.001) after controlling for possible confounding variables including age, parity and initial weight. Use of DMPA is associated with significant weight gain in Navajo women. This weight gain is greater than that reported in previous uncontrolled studies in non-Navajo populations. This information should be utilized in counseling Navajo women about the side effects of DMPA. (C) 2000 Elsevier Science Inc, All rights reserved.
引用
收藏
页码:55 / 58
页数:4
相关论文
共 15 条
  • [1] [Anonymous], VITAL HLTH STAT
  • [2] Contraceptive use among adolescent mothers at 6 months postpartum
    Berenson, AB
    Wiemann, CM
    [J]. OBSTETRICS AND GYNECOLOGY, 1997, 89 (06) : 999 - 1005
  • [3] EFFECT OF LONG-TERM HORMONAL CONTRACEPTION ON PLASMA-LIPIDS
    DESLYPERE, JP
    THIERY, M
    VERMEULEN, A
    [J]. CONTRACEPTION, 1985, 31 (06) : 633 - 642
  • [4] Effect of pretreatment counseling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception
    Lei, ZW
    Wu, SC
    Garceau, RJ
    Jiang, S
    Yang, QZ
    Wang, WL
    VanderMeulen, TC
    [J]. CONTRACEPTION, 1996, 53 (06) : 357 - 361
  • [5] LIEU DFM, 1985, CONTRACEPTION, V35, P51
  • [6] METABOLIC PARAMETER, BLEEDING, AND WEIGHT CHANGES IN US WOMEN USING PROGESTIN ONLY CONTRACEPTIVES
    MAINWARING, R
    HALES, HA
    STEVENSON, K
    HATASAKA, HH
    POULSON, AM
    JONES, KP
    PETERSON, CM
    [J]. CONTRACEPTION, 1995, 51 (03) : 149 - 153
  • [7] A COMPARATIVE-STUDY OF ONE-YEAR WEIGHT-GAIN AMONG USERS OF MEDROXYPROGESTERONE ACETATE, LEVONORGESTREL IMPLANTS, AND ORAL-CONTRACEPTIVES
    MOORE, LL
    VALUCK, R
    MCDOUGALL, C
    FINK, W
    [J]. CONTRACEPTION, 1995, 52 (04) : 215 - 219
  • [8] MUKHERJEA M, 1980, INT J FERTIL, V25, P122
  • [9] Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents
    O'dell, CM
    Forke, CM
    Polaneczky, MM
    Sondheimer, SJ
    Slap, GB
    [J]. OBSTETRICS AND GYNECOLOGY, 1998, 91 (04) : 609 - 614
  • [10] Depot medroxyprogesterone acetate - Patterns of use and reasons for discontinuation
    Paul, C
    Skegg, DCG
    Williams, S
    [J]. CONTRACEPTION, 1997, 56 (04) : 209 - 214